219 related articles for article (PubMed ID: 17369840)
1. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
McCabe NP; De S; Vasanji A; Brainard J; Byzova TV
Oncogene; 2007 Sep; 26(42):6238-43. PubMed ID: 17369840
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.
Sloan EK; Pouliot N; Stanley KL; Chia J; Moseley JM; Hards DK; Anderson RL
Breast Cancer Res; 2006; 8(2):R20. PubMed ID: 16608535
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.
Nemeth JA; Cher ML; Zhou Z; Mullins C; Bhagat S; Trikha M
Clin Exp Metastasis; 2003; 20(5):413-20. PubMed ID: 14524530
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
[TBL] [Abstract][Full Text] [Related]
5. Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.
Ross MH; Esser AK; Fox GC; Schmieder AH; Yang X; Hu G; Pan D; Su X; Xu Y; Novack DV; Walsh T; Colditz GA; Lukaszewicz GH; Cordell E; Novack J; Fitzpatrick JAJ; Waning DL; Mohammad KS; Guise TA; Lanza GM; Weilbaecher KN
Cancer Res; 2017 Nov; 77(22):6299-6312. PubMed ID: 28855208
[TBL] [Abstract][Full Text] [Related]
6. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
[TBL] [Abstract][Full Text] [Related]
7. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
King TE; Pawar SC; Majuta L; Sroka IC; Wynn D; Demetriou MC; Nagle RB; Porreca F; Cress AE
PLoS One; 2008; 3(10):e3535. PubMed ID: 18958175
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathway for cancer metastasis to bone.
De S; Chen J; Narizhneva NV; Heston W; Brainard J; Sage EH; Byzova TV
J Biol Chem; 2003 Oct; 278(40):39044-50. PubMed ID: 12885781
[TBL] [Abstract][Full Text] [Related]
9. Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.
Singh A; Fedele C; Lu H; Nevalainen MT; Keen JH; Languino LR
Mol Cancer Res; 2016 Nov; 14(11):1136-1146. PubMed ID: 27439335
[TBL] [Abstract][Full Text] [Related]
10. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
[TBL] [Abstract][Full Text] [Related]
11. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
[TBL] [Abstract][Full Text] [Related]
12. Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells.
Pola C; Formenti SC; Schneider RJ
Cancer Res; 2013 Jul; 73(14):4571-8. PubMed ID: 23722547
[TBL] [Abstract][Full Text] [Related]
13. CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration.
Lin TH; Liu HH; Tsai TH; Chen CC; Hsieh TF; Lee SS; Lee YJ; Chen WC; Tang CH
Biochim Biophys Acta; 2013 Oct; 1830(10):4917-27. PubMed ID: 23845726
[TBL] [Abstract][Full Text] [Related]
14. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
15. Definition of molecular determinants of prostate cancer cell bone extravasation.
Barthel SR; Hays DL; Yazawa EM; Opperman M; Walley KC; Nimrichter L; Burdick MM; Gillard BM; Moser MT; Pantel K; Foster BA; Pienta KJ; Dimitroff CJ
Cancer Res; 2013 Jan; 73(2):942-52. PubMed ID: 23149920
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen interaction of CHO cells expressing chimeric alphaIIb/alphavbeta3 integrin.
Chen JJ; Su XY; Xi XD; Lin LP; Ding J; Lu H
Acta Pharmacol Sin; 2008 Feb; 29(2):204-10. PubMed ID: 18215349
[TBL] [Abstract][Full Text] [Related]
17. Avβ3 integrin: Pathogenetic role in osteotropic tumors.
Stucci S; Tucci M; Passarelli A; Silvestris F
Crit Rev Oncol Hematol; 2015 Oct; 96(1):183-93. PubMed ID: 26126493
[TBL] [Abstract][Full Text] [Related]
18. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
19. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions.
Yonou H; Ochiai A; Goya M; Kanomata N; Hokama S; Morozumi M; Sugaya K; Hatano T; Ogawa Y
Prostate; 2004 Mar; 58(4):406-13. PubMed ID: 14968441
[TBL] [Abstract][Full Text] [Related]
20. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
